These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy. Mell LK; Kochanski JD; Roeske JC; Haslam JJ; Mehta N; Yamada SD; Hurteau JA; Collins YC; Lengyel E; Mundt AJ Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1356-65. PubMed ID: 16757127 [TBL] [Abstract][Full Text] [Related]
64. Intra-arterial chemotherapy with mitomycin C in gallbladder cancer: a follow-up study. Bode MK; Perälä J; Mäkelä JT; Leinonen S J Surg Oncol; 2005 Aug; 91(2):102-6. PubMed ID: 16028283 [TBL] [Abstract][Full Text] [Related]
65. [Mitomycin-induced pulmonary veno-occlusive disease: A rare but severe complication]. Montani D; Chaumais MC; Seferian A; Humbert M Bull Cancer; 2017 Feb; 104(2):202-204. PubMed ID: 27884394 [No Abstract] [Full Text] [Related]
66. Response to Letter Regarding Article, "Mitomycin-Induced Pulmonary Veno-Occlusive Disease: Evidence From Human Disease and Animal Model". Perros F; Günther S; Ranchoux B; Godinas L; Antigny F; Chaumais MC; Dorfmüller P; Hautefort A; Raymond N; Savale L; Jaïs X; Girerd B; Cottin V; Sitbon O; Simonneau G; Humbert M; Montani D Circulation; 2016 Apr; 133(14):e592-3. PubMed ID: 27045136 [No Abstract] [Full Text] [Related]
67. Letter by Belge et al Regarding Article, "Mitomycin-Induced Pulmonary Veno-Occlusive Disease: Evidence From Human Disease and Animal Models". Belge C; Quarck R; Delcroix M Circulation; 2016 Apr; 133(14):e591. PubMed ID: 27045135 [No Abstract] [Full Text] [Related]
68. WS1279, a novel lipopeptide isolated from Streptomyces willmorei. Biological activities. Tanaka M; Hori Y; Sakai F; Ueda H; Goto T; Okuhara M; Tsuda Y; Okada Y J Antibiot (Tokyo); 1993 Nov; 46(11):1699-706. PubMed ID: 8270492 [TBL] [Abstract][Full Text] [Related]
70. Comprehensive treatment experience of anal squamous cell carcinoma from a tertiary cancer center in South China. Yuan Y; Xie WH; Li RZ; Chang H; Zeng ZF; Gao YH; Wang QX; Xiao WW Cancer Med; 2022 Jan; 11(1):117-127. PubMed ID: 34816622 [TBL] [Abstract][Full Text] [Related]
72. Unexpected increase in the bone marrow toxicity of mitomycin C (MMC). Yoshimoto M; Saito M; Tada T; Kasumi KT Br J Cancer; 2001 Mar; 84(5):736-7. PubMed ID: 11237399 [No Abstract] [Full Text] [Related]
73. [Intraperitoneal chemotherapy with mitomycin C bound to activated carbon nanoparticles for nude mice bearing human gastric carcinoma]. Qu QL; Zhang YG; Yang LZ; Sun L Zhonghua Zhong Liu Za Zhi; 2006 Apr; 28(4):257-60. PubMed ID: 16875622 [TBL] [Abstract][Full Text] [Related]
74. [What we can learn from a case of medical malpractice]. Kato S; Kobayashi H; Makita S; Kuwabara H Nihon Geka Gakkai Zasshi; 2005 Apr; 106(4):320. PubMed ID: 15859146 [No Abstract] [Full Text] [Related]
75. [Lung sarcoidosis following instillation of mitomycin C in the urinary bladder]. Cuervo Pinna MA; Cuervo Pinna C; Macías Castillo S; Bureo Dacal JC; Espada Alonso MJ; Pimentel Leo J An Med Interna; 2001 Dec; 18(12):641-3. PubMed ID: 11852501 [TBL] [Abstract][Full Text] [Related]
76. Therapeutic effects of Lycium barbarum polysaccharide (LBP) on mitomycin C (MMC)-induced myelosuppressive mice. Hai-Yang G; Ping S; Li JI; Chang-Hong X; Fu T J Exp Ther Oncol; 2004 Oct; 4(3):181-7. PubMed ID: 15724837 [TBL] [Abstract][Full Text] [Related]